video
2dn
video2dn
Найти
Сохранить видео с ютуба
Категории
Музыка
Кино и Анимация
Автомобили
Животные
Спорт
Путешествия
Игры
Люди и Блоги
Юмор
Развлечения
Новости и Политика
Howto и Стиль
Diy своими руками
Образование
Наука и Технологии
Некоммерческие Организации
О сайте
Видео ютуба по тегу Sarah Cannon
Jon Cannon of NHPBS Quizzes Sarah
Allogeneic CAR-T Cell Therapy for Multiple Myeloma Jesus Berdeja, MD, Sarah Cannon
HR+ рак молочной железы: применение инаволисиба в качестве терапии первой линии и новые адъювантн...
Outpatient use of liso-cel in patients with R/R LBCL: real-world data from the CIBMTR registry
Sequencing HER2+ therapies in breast cancer: insights on ADCs, TKIs, chemo, & maintenance strategies
Quality improvement initiative to optimize AE management for bispecifics for DLBCL in the community
Phase I trial of LY4152199, a BAFF-R-targeting bispecific, in previously treated B-cell malignancies
HER2CLIMB-05: tucatinib improves progression-free survival in HER2+ metastatic breast cancer
Bispecific antibodies in myeloma: top trial updates from ASH 2025
CAR T-Cell Therapy Insights from the Field
Lung Cancer Awareness: Dr. Melissa Johnson on Early Detection & Breakthrough Treatment|NewsChannel 5
Blood & Marrow Transplant 101 - Sarah Cannon Cancer Network (Spanish)
Клинические испытания: луч надежды для пациентов с раком поджелудочной железы
HR-Positive Metastatic Breast Cancer — An Interview with Dr Erika Hamilton on the Potential Role ...
HR-Positive Metastatic Breast Cancer — An Interview with Dr Erika Hamilton on the Potential Role ...
Together, Cancer Doesn't Stand a Chance
Clinical Trials Driving Hope in Pancreatic Cancer: Jason Henry's Inspiring Story
Clinical Trials Driving Hope in Pancreatic Cancer: Jason Henry's Inspiring Story
Episode 519 Dishing the Tea with Event Coordinator Sarah Cannon
Episode 180 Sawgrass and Sublimation with Sarah Cannon
Новости о метастатическом раке молочной железы: SERD, ингибиторы mTOR и VIKTORIA-1
Dr. Mohammad Mozayen's Treatment Approach - Sarah Cannon
Bringing clinical trials to the community: current approaches at Sarah Cannon Research Institute
Durability of responses in patients with DLBCL treated with liso-cel: real-world insights
The growing role of quadruplet-based regimens in newly diagnosed multiple myeloma
Следующая страница»